Lv41
574 积分 2025-06-26 加入
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
5小时前
已完结
Engineering challenges and translational opportunities in emerging gene delivery platforms
22天前
已完结
Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer
2个月前
已完结
Prostate cancer
2个月前
已完结
mRNA lipid nanoparticle formulation, characterization and evaluation
2个月前
已完结
Preparation of targeted lipid nanoparticles for precision nucleic acid delivery
2个月前
已完结
Controlling Payload Heterogeneity in Lipid Nanoparticles for RNA-Based Therapeutics
2个月前
已完结
Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models
2个月前
已完结
Therapeutic application of circular RNA aptamers in a mouse model of psoriasis
2个月前
已完结
Preparation of targeted lipid nanoparticles for precision nucleic acid delivery
2个月前
已完结
皖公网安备34019202002308
